Skip to content

To compare hand held ultraviolet device verses whole body ultraviolet device in treatment of vitiligo patient

An open label non- randomized preliminary study comparing hand-held Narrow Band UVB device with standard whole body Narrow Band UVB therapy in treatment of localized vitiligo

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020818
Enrollment
15
Registered
2019-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: HANDHELD NB-UVB THERAPY: Duration of exposure at each site (seconds): Every time on switching the device and stop watch simultaneously then start exposing to the representative patches

Sponsors

AIIMS DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Consecutive patients of localized vitiligo involving b) Patients >=18 years of age. c) Patients who have not taken any topical therapy in last 2 weeks or systemic therapy in last 4 weeks d) Patients giving consent for using hand held NB-UVB and whole body NB-UVB therapy

Exclusion criteria

Exclusion criteria: a) Patients with rapidly spreading vitiligo. b) Patients with recalcitrant forms of vitiligo i.e., lip-tip vitiligo, segmental vitiligo and with predominant leukotrichia on patches. c) Patients with concomitant photo-aggravated dermatoses. d) Patients who are unable to maintain the NB-UVB device.

Design outcomes

Primary

MeasureTime frame
Comparison of percentage of repigmentation of the representative vitiligo patch at the end of 4 months of treatment between the two study groups.Timepoint: over 4 months of treatment

Secondary

MeasureTime frame
Comparison of percentage repigmentation in vitiligo between the two groups based on global assessment using Lund and Browder score Assessment ofrepigmentation using photographic assessment investigator global assessment Comparison of patients perspective of repigmentation in vitiligo by Patient global assessment score using visual analogue scale from 0-10 Change in dermatology life quality index using Tjioe M et al questionnaire Qualities of life (QOL) score using VIS-22Timepoint: over 4 month of treatment

Countries

India

Contacts

Public ContactDr Suvesh singh

AIIMS NEW DELHI

sujay_khandpur@yahoo.com011-26594442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026